EMBL Ventures was founded in 2001 in Heidelberg, directly linked to the European Molecular Biology Laboratory — one of the world's most prestigious molecular biology research institutions. Managing three funds with €120M total capital from major European private and institutional investors, the fund focuses on therapeutics, diagnostics, target validation, drug design, technology platforms, and med...
London, United Kingdom
Berlin, Germany
Paris, France
Basel, Switzerland
Melbourne, Australia
Bad Homburg, Germany